DailyDoctor Archive Specialties Get app
All emergency & critical care briefings

The edition · Emergency & Critical Care

An Indian ICU trial found chlorhexidine added nothing to a good oral-care bundle

Removing chlorhexidine did not raise pneumonia rates, every hour of delay to antifungals in Candida shock tracked with lower survival, and recommended paediatric CPR ventilation rates were not linked to outcome.

The edition in brief

A cluster-randomised crossover trial in six medical ICUs in Bhubaneswar (Critical Care, 29 October) found adding 0.12% chlorhexidine to a standardised oral-care bundle did not reduce ventilator-associated pneumonia (18.8 vs 16.9 per 1000 ventilator-days; IRR 1.08) or 28-day mortality, and ICU stay was about 0.9 days longer. In 850 patients with culture-positive Candida septic shock across 32 hospitals (Critical Care Medicine, 21 October), survival was 86% when an appropriate antifungal started within two hours of persistent hypotension and fell about 5% per hour of delay thereafter; the median delay was 32 hours. An ICU-RESUS ancillary cohort of 234 paediatric in-hospital arrests (Critical Care Medicine, 14 October) found ventilation rates within the recommended 20 to 30 per minute were not associated with survival; exploratory analysis suggested higher rates may help under-8s. The FDA lists a supplement to an epinephrine new drug application dated 19 October; the record does not state its content. The pearl covers waveform capnography after intubation.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free